Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
Related Research units
Abstract
The activity of rituximab in pediatric B-cell non-Hodgkin's lymphoma (B-NHL) has not yet been determined. We conducted a phase II window study to examine activity and tolerability of rituximab in newly diagnosed pediatric B-NHL.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 19 |
| ISSN | 0732-183X |
| Publication status | Published - 2010 |
| pubmed | 20516455 |
|---|
